127 related articles for article (PubMed ID: 19754482)
1. Influence of splitting on dissolution properties of metoprolol tablets.
Vranić E; Uzunović A
Bosn J Basic Med Sci; 2009 Aug; 9(3):245-9. PubMed ID: 19754482
[TBL] [Abstract][Full Text] [Related]
2. Use of natural gums and cellulose derivatives in production of sustained release metoprolol tablets.
Varshosaz J; Tavakoli N; Eram SA
Drug Deliv; 2006; 13(2):113-9. PubMed ID: 16423799
[TBL] [Abstract][Full Text] [Related]
3. Tablet splitting: Product quality assessment of metoprolol succinate extended release tablets.
Zhao N; Zidan A; Tawakkul M; Sayeed VA; Khan M
Int J Pharm; 2010 Nov; 401(1-2):25-31. PubMed ID: 20849940
[TBL] [Abstract][Full Text] [Related]
4. Development and internal validation of an in vitro-in vivo correlation for a hydrophilic metoprolol tartrate extended release tablet formulation.
Eddington ND; Marroum P; Uppoor R; Hussain A; Augsburger L
Pharm Res; 1998 Mar; 15(3):466-73. PubMed ID: 9563079
[TBL] [Abstract][Full Text] [Related]
5. Core-in-cup tablet design of metoprolol succinate and its evaluation for controlled release.
Nagaraju R; Meera DS; Kaza R; Arvind VV; Venkateswarlu V
Curr Drug Discov Technol; 2009 Dec; 6(4):299-305. PubMed ID: 20025598
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of in vitro release rate and in vivo absorption characteristics of four metoprolol tartrate immediate-release tablet formulations.
Rekhi GS; Eddington ND; Fossler MJ; Schwartz P; Lesko LJ; Augsburger LL
Pharm Dev Technol; 1997 Feb; 2(1):11-24. PubMed ID: 9552427
[TBL] [Abstract][Full Text] [Related]
7. Optimization of fluid bed formulations of metoprolol granules and tablets using an experimental design.
Tomuţă I; Alecu C; Rus LL; Leuçuta SE
Drug Dev Ind Pharm; 2009 Sep; 35(9):1072-81. PubMed ID: 19353417
[TBL] [Abstract][Full Text] [Related]
8. Formulation and evaluation of delayed-onset extended-release tablets of metoprolol tartrate using hydrophilic-swellable polymers.
Dadarwal SC; Madan S; Agrawal SS
Acta Pharm; 2012 Mar; 62(1):105-14. PubMed ID: 22472453
[TBL] [Abstract][Full Text] [Related]
9. Fabrication of modified release tablet formulation of metoprolol succinate using hydroxypropyl methylcellulose and xanthan gum.
Gohel MC; Parikh RK; Nagori SA; Jena DG
AAPS PharmSciTech; 2009; 10(1):62-8. PubMed ID: 19148762
[TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of metoprolol controlled-release solid dispersions.
Varshosaz J; Faghihian H; Rastgoo K
Drug Deliv; 2006; 13(4):295-302. PubMed ID: 16766471
[TBL] [Abstract][Full Text] [Related]
11. Process analytical technology: chemometric analysis of Raman and near infra-red spectroscopic data for predicting physical properties of extended release matrix tablets.
Shah RB; Tawakkul MA; Khan MA
J Pharm Sci; 2007 May; 96(5):1356-65. PubMed ID: 17455359
[TBL] [Abstract][Full Text] [Related]
12. Optimization of sustained release matrix tablet of metoprolol succinate using central composite design.
Li L; Sun H; Gao J; Jiang T; Gao Y; Zhang J
Pak J Pharm Sci; 2013 Sep; 26(5):929-37. PubMed ID: 24035948
[TBL] [Abstract][Full Text] [Related]
13. Formulation and in-vitro evaluation of floating bilayer tablet of lisinopril maleate and metoprolol tartrate.
Ijaz H; Qureshi J; Danish Z; Zaman M; Abdel-Daim M; Hanif M; Waheed I; Mohammad IS
Pak J Pharm Sci; 2015 Nov; 28(6):2019-25. PubMed ID: 26639495
[TBL] [Abstract][Full Text] [Related]
14. Compritol®888 ATO a lipid excipient for sustained release of highly water soluble active: formulation, scale-up and IVIVC study.
Patere SN; Desai NS; Jain AS; Kadam PP; Thatte UM; Gogtay N; Kapadia CJ; Farah N; Nagarsenker MS
Curr Drug Deliv; 2013 Oct; 10(5):548-56. PubMed ID: 23607649
[TBL] [Abstract][Full Text] [Related]
15. Development of injection moulded matrix tablets based on mixtures of ethylcellulose and low-substituted hydroxypropylcellulose.
Quinten T; Gonnissen Y; Adriaens E; De Beer T; Cnudde V; Masschaele B; Van Hoorebeke L; Siepmann J; Remon JP; Vervaet C
Eur J Pharm Sci; 2009 Jun; 37(3-4):207-16. PubMed ID: 19491007
[TBL] [Abstract][Full Text] [Related]
16. Polymer leaching from film coating: effects on the coating transport properties.
Marucci M; Ragnarsson G; von Corswant C; Welinder A; Jarke A; Iselau F; Axelsson A
Int J Pharm; 2011 Jun; 411(1-2):43-8. PubMed ID: 21421031
[TBL] [Abstract][Full Text] [Related]
17. Badam gum: a natural polymer in mucoadhesive drug delivery. Design, optimization, and biopharmaceutical evaluation of badam gum-based metoprolol succinate buccoadhesive tablets.
Mylangam CK; Beeravelli S; Medikonda J; Pidaparthi JS; Kolapalli VR
Drug Deliv; 2016; 23(1):195-206. PubMed ID: 24825493
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the Clinical Impact of Formulation Variability: A Metoprolol Extended-Release Case Study.
Kim S; Sharma VD; Lingineni K; Farhan N; Fang L; Zhao L; Brown JD; Cristofoletti R; Vozmediano V; Ait-Oudhia S; Lesko LJ; Trame MN; Schmidt S
J Clin Pharmacol; 2019 Sep; 59(9):1266-1274. PubMed ID: 31087554
[TBL] [Abstract][Full Text] [Related]
19. Comparative bioavailability of a metoprolol controlled release formulation and a bisoprolol normal release tablet after single oral dose administration in healthy volunteers.
Deroubaix X; Lins RL; Lens S; Demblon C; Jeanbaptiste B; Poelaert D; Stockis A
Int J Clin Pharmacol Ther; 1996 Feb; 34(2):61-70. PubMed ID: 8929748
[TBL] [Abstract][Full Text] [Related]
20. In vitro to in vivo profiling: an easy idea for biowaiver study.
Khaled AA; Pervaiz K; Khiljee S; Karim S; Shoaib QU; Murtaza G
Acta Pol Pharm; 2013; 70(5):873-5. PubMed ID: 24147366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
